Immunogenicity of a rat leukaemia of spontaneous origin (SAL). by Wrathmell, A. B. & Alexander, P.
Br. J. Cancer (1976) 33, 181
IMMUNOGENICITY OF A RAT LEUKAEMIA
OF SPONTANEOUS ORIGIN (SAL)
A. B. WRIATHMELL AND P. ALEXANDER
From, the Division of Tumtour Immunology, Chester Beatty Research Institute,
Jnstitute of Cancer Research,: Royal Cancer Hospital, Clifton Avenue, Belmont, Sutton, Surrey,
Received 4 September 1975 Accepte(d 4 October 1975
Summary.-The SAL rat leukaemia, which resembles acute myeloblastic leukaemia,
appeared initially to be non-immunogenic since resistance to an i.p. challenge with
as few as 100 cells could not be obtained using stimulation ofthe RES or by immuniz-
ation with SAL cells exposed to x-rays, nitrogen mustard, iodoacetate or glutaral-
dehyde. However, immunization with SAL cells exposed to low doses of mitomycin-
C slowed the growth of the challenge inoculum. Cells treated with high doses of
mitomycin-C did not immunize. The results are interpreted in terms of rapid
shedding of a tumour-specific antigen from the membrane of SAL cells.
THE MOST convincing method of
demonstrating the presence of tumour-
specific transplantation-type antigens
(TSTAs) in the membrane of malignant
cells is by inducing specific resistance to
tumour grafts in syngeneic recipients by
immunization. An effective way of pro-
ducing immunity is to ligate or excise a
growing tumour, but this procedure
cannot be used for blood-borne leukae-
mias or if the tumours metastasize
spontaneously. An alternative procedure
by which immunity; has' been produced
to many types of experimental tumours
is by inoculation of intact tumour cells
that have been rendered incapable of
dividing, but which remain at least for a
time, physiologically viable and maintain
an intact membrane. " Sterilization " of
tumour cells for immunization is usually
achieved by exposing cells to x-rays
although a number of cytotoxic agents
have also proved effective. Using either
technique, i.e. removal of a growing
tumour or injection of " sterilized " cells
most but not all-chemically and virally
induced tumours could be shown to carry
TSTAs capable of invoking immunity to
challenge. On the other hand, there are
several reports which show that it is
frequently not possible to demonstrate
resistance against tumours which have
arisen spontaneously in pure line experi-
mental animals (Prehn and Main, 1957;
Baldwin, 1966).
This paper describes an investigation
into the immunogenicity in vivo of the
transplantable rat leukaemia referred to
as SAL-which arose spontaneously in an
August rat and which can be transplanted
into syngeneic rats with as few as 10 cells
(Wrathmell and Alexander, 1973;
Wrathmell, 1976). This tumourhas many
characteristicsofacutemyeloblastic leukae-
mia and disseminates rapidly to bone
marrow and blood. At the time of death
there are in excess of 100,000 blast cells/
mm3 of blood. Evidence for host
resistance directed against a TSTA carried
by SAL cells was sought by testing if
resistance to challenge with live SAL cells
could be induced in the syngeneic host
either by immunizing with SAL cells that
had been " sterilized " with x-rays, by
stimulation of the reticuloendothelial
system (RES)with BCG or Corynebacterium
parvum, or by chemical treatment of the
leukaemia cells.
Various chemical methods have been
used to render tumour cells non-viable forA. B. WRATHMELL AND P. ALEXANDER
immunization and have been reviewed by
Prager and Baechtel (1973). For this
study we used a cross-linking agent;
glutaraldehyde, a sulphydryl blocking
agent; sodium iodoacetate, and 2 anti-
mitotic drugs: nitrogen mustard (Mustine)
and mitomycin-C.
Both glutaraldehyde and sodium iodo-
acetate have been shown to improve the
immunogenicity of tumour cells in other
systems (Sanderson and Frost, 1974;
Apffel, Arnason and Peters, 1966).
Mitomycin-C is used as an inhibitor of cell
division in the mixed lymphocyte reaction
in vitro, and nitrogen mustard has
previously been employed to attenuate
tumour cells for immunization purposes
(Ishidate et al., 1965).
MATERIALS AND METHODS
Aninmals and tumour used.-Pure line
August rats were bred in the Institute's
colony and used at 8-10 weeks of age. The
Sutton August Leukaemia SAL (Wrathmell,
1976) was serially transplanted in syngeneic
August rats using cells derived from the
blood of leukaemic rats. SAL cells were
obtained by centrifuging the blood from
leukaemic rats at 500 g for 5 min and then
resuspending the cells in medium 199. The
SAL cells used for immunization were ob-
tained from the spleens of leukaemic rats
since large numbers of cells could be obtained
in this way. The cells were washed and
resuspended in TC 199.
Immunization procedure.-Rats were
immunized at 4 subcutaneous sites and
intraperitoneally with SAL cells suspended
in 1.0 ml of TC 199, the number of cells
injected being specified in the text. Two
injections were given at 10-day intervals and
t,he rats challenged 10 days after the second
immunization.
Preparation of cells for immunization.-
SAL spleen cells were washed andresuspended
in TC 199 at a concentration of 5 x 107
cells/ml and then immediately x-irradiated at
a dose rate of 800 rad/min from a 200 kV
Marconi x-ray machine (no filter) at room
temperature and under well oxygenated
conditions. Cells were incubated with mito-
mycin-C (Dales Pharmaceuticals) at the
concentrations stated in the text for 30 min
at 37°C on a blood suspension mixer. Similar
conditions were used for treating cells wNith
nitrogen mustard (Mustine hydrochloride,
Boots Company Ltd). Treatment w%Aith
0.25% glutaraldehyde in phosphate buffered
saline was carried out for 15 min at 22°C at a
concentration of 108 cells/ml 0-001 mol/l
Sodium iodoacetate in PBS was incubated
wNith 3 x 107 SAL cells/ml at 37°C for 1 h.
Following all chemical treatments the cells
were washed 3 times before use.
In order to stimulate the RES either
BCG or Corynebacterium parvum was mixed
together with irradiated SAL cells for immu-
nization so that each rat received 1 ml
containing 107 cells and either 300 ,ug BCG
or 0 7 mg C. paruttm (wet weights).
RESULTS
The Table and Fig. 1 show that
immunization at multiple sites with xW
irradiated SAL cells does not provide
protection against an i.p. challenge with
as few as 100 leukaemia cells. The
lowest dose of irradiation which could be
used to prepare the " vaccine " was 2000
rad of x-rays (irradiation occurring under
oxygenated conditions). If the inoculum
is exposed to lower doses, some ofthe SAL
cells retain the capacity to proliferate and
induce leukaemia. Attempts to augment
the immunogenicity of x-irradiated SAL
cells by mixing with either BCG or
C. parvum as an adjuvant were also
unsuccessful in inducing resistance.
Similarly, nonspecific stimulation of the
RES by injecting either BCG or C. parvum
alone before inoculating living SAL cells
did not increase the capacity of August
rats to resist a challenge of SAL cells.
Gross (1970) had found in guinea-pigs
that resistance to leukaemic cells was
expressed more strongly if the cells used
for challenge were injected intradermally
rather than by other routes. We there-
fore comparedthe susceptibility of August
rats, following hyperimmunization with
irradiated (5000 rad) SAL cells to chal-
lenge with 100 SAL cells given i.v., i.p. or
s.c. and to 500 SAL cells given i.d. It was
necessary to increase the i.d. challenge
dose since when given by this route 100
SAL cells did Inot cause tumours in all of
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TABLE.-Effect of Immunization of August Rats against a Challenge of 100
Live SAL Cells i.p.
Survival time in days of rats following
inoculation of 100 SAL cells i.p.
Treatment of host 7 and 14
days before challenge anim
None
BCG (300,g)
C. parvum (O 7 mg)
Immunized with SAL cells
treated with:
2000 rad x-rays
4000 rad x-rays
6000 rad x-rays
8000 rad x-rays
5000 rad x-rays + BCG/300 Mg)
5000 rad x-rays + C. parvum (O 7 mg)
Nitrogen mustard
(10,g/l07 cells/ml)
lodoacetate (0 001 mol/l)
Glutaraldehyde (0 25%)
* Results of 2 separate experiments pooled.
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Fic I.--Resistance of August rats immunized with x-irradiated SAL cells to a challenge of live SAL
cells given at different sites.,.J{ .. .~~~~~~~~~~~~ NonleA. B. WRATHMELL AND P. ALEXANDER
the control animals. Figure 1 shows that
resistance following immunization with
irradiated cells is detectable using i.d.
challenge but is not detectable following
challenges i.v., i.p. or s.c., suggesting that
the SAL is of weak immunogenicity.
More decisive evidence for the presence
of a TSTA on SAL cells came from
experiments in which the cells used for
immunization were rendered incapable of
growth by treatment with mitomycin-C
(see Fig. 2). As is to be anticipated for a
compound which combines with macro-
molecules within the cell, the concentration
of mitomycin-C needed to render SAL
cells incapable of growth depended on the
number of cells present in a given volume.
Three concentrations, 25 jag, 10 ,ug and
5 ,ag/ml, were tested on different cell
concentrations from 106 to 108 cells/ml.
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The critical concentrations of mitomy-
cin-C and SAL cells for sterilization were
5 ,ag/107 cells/ml and multiples of these
concentrations, e.g. 0 5 ,ug/106 cells/ml or
50 jug/108 cells/ml. Figure 1 shows that
only the minimum dose of mitomycin-C
necessary for " sterilization " gave cells
that were capable ofprotecting against an
i.p. challenge with SAL cells. Optimally
treated mitomycin-C SAL cells retain their
protective action after extensive washing
and this, as well as the dose dependence,
shows that the protective effect cannot be
attributed to a carry-over of mitomycin-C
into the host. That this protection is
specific is indicated by the fact that
immunization with mitomycin-C treated
normal August spleen cells does not
render August rats more resistant to
subsequent challenge withSAL (seeFig. 2).
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FIG. 2-The effect of immunization with mitomycin-C treated SAL cells on survival of August rats
following challenge with 100 SAL cells i.p.
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Cells killed by treatment with iodo-
acetate (Apffel et at., 1966; Wang and
Halliday, 1966), nitrogen mustard (Ishi-
date et al., 1965) or glutaraldehyde
(Sanderson and Frost, 1974) have all been
found to immunize syngeneic mice against
a variety of tumours, and in some cases
gave better protection than x-irradiated
cells. SAL cells treated with these
chemicals at the stated concentrations
failed to immunize August rats against
SAL cells (see Table).
DISCUSSION
Failure to induce resistance by prior
immunization to challenge with syngeneic
tumour cells does not necessarily imply
that the tumour cells are without tumour
specific transplantation-type antigens
(TSTAs) to which the host makes an
immune response. Immunogenicity,
when assessed by the number of cells that
are rejected after immunization, is a
complex parameter involving the magni-
tude of the host response to TSTAs and
the vulnerability oftheinjected cells to the
host defences. Thus, Currie and
Alexander (1974) found that the host
response-as assayed in vitro-to the
TSTAs of 2 different sarcomata was very
similar, yet the degree of resistance to
challenge that could be evoked by immun-
ization varied greatly. Failure by the
immune rats to reject effectively one of
the sarcomata was attributed to the
shedding of TSTAs which form a protec-
tive screen around the tumour cells.
The finding that with some sarcomata-
notably those that metastasize-a specific
immune response can be evoked by a
growing tumour but not by immunization
with irradiated tumour cells may also be
related to differences in the rate at which
the tumour cells spontaneously shed their
TSTAs (Proctor, Rudenstam and Alex-
ander, 1974). The concentration of
TSTAs in the membrane must be main-
tained by new synthesis which
compensates forloss by shedding. Hence,
interference with protein synthesis by
procedures such as exposure to x-rays,
which are used to sterilize cells for
immunization, is likely to reduce to a
greater extent the concentration ofTSTAs
in the membrane of tumours with the
higher rate ofshedding. Alexander (1974)
has advanced the hypothesis that rapid
spontaneous shedding of TSTAs results in
(1) a high rate of metastatic spread, (2)
inability of immunized animals to reject
large inocula of tumour cells and (3)
failure of cells exposed to x-rays to induce
immunity. The rapidity with which SAL
leukaemia disseminates is consistent with
a tumour that has a high rate of TSTA
shedding-unfortunately direct proof of
this has not been obtained as we have been
unable to grow SAL cells in vitro. A
possible interpretation for the finding that
SAL cells sterilized with low doses of
mitomycin-C can induce weak resistance
to challenge whereas those exposed to
x-rays induce essentially no resistance at
all, could be explained by the fact that
x-rays interfere to a greater extent than
does mitomycin-C with the new synthesis
ofTSTAs needed to replace those that are
shed. Hence, cells sterilized with
mitomycin-C will be more immunogenic
than those sterilized by x-ray. It is
known that at low doses mitomycin-C can
prevent cell division by direct combination
with DNA while leaving RNA and protein
synthesis unaffected (Shatkin et al., 1962;
Szybalski and Jyer, 1964). It is interest-
ing that Scollay, Lafferty and Poskitt
(1974) found that lymphocytes lost their
capacity to stimulate allogeneic cells in
vitro after treatment with high, but not
with low, concentrations of mitomycin-C.
Whatever the mechanism responsible for
the failure to immunize against SAL with
x-irradiated cells, when detectable pro-
tection can be obtained with mitomycin-C
treated cells, these experiments highlight
the problem of deciding if any tumour
does not have TSTAs.
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